George Perez

1.2k total citations
36 papers, 785 citations indexed

About

George Perez is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, George Perez has authored 36 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 13 papers in Epidemiology and 10 papers in Virology. Recurrent topics in George Perez's work include HIV Research and Treatment (10 papers), HIV/AIDS Research and Interventions (10 papers) and HIV/AIDS drug development and treatment (8 papers). George Perez is often cited by papers focused on HIV Research and Treatment (10 papers), HIV/AIDS Research and Interventions (10 papers) and HIV/AIDS drug development and treatment (8 papers). George Perez collaborates with scholars based in United States, Cuba and Germany. George Perez's co-authors include Jihad Slim, Thomas N. Denny, Hamid Shaaban, Joan Skurnick, Lawrence S. Brown, John P. Matts, Sunil Daniel, Donald B. Louria, Wafaa El‐Sadr and Richard Hafner and has published in prestigious journals such as New England Journal of Medicine, American Journal of Clinical Nutrition and Clinical Infectious Diseases.

In The Last Decade

George Perez

36 papers receiving 745 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
George Perez United States	15	413	353	169	143	108	36	785
Angelike P. Liappis United States	13	181 0.4×	286 0.8×	108 0.6×	160 1.1×	193 1.8×	30	729
Vincenzo Spagnuolo Italy	17	643 1.6×	185 0.5×	521 3.1×	217 1.5×	95 0.9×	99	979
Natsuo Tachikawa Japan	16	533 1.3×	284 0.8×	217 1.3×	92 0.6×	51 0.5×	74	999
Annette Haberl Germany	18	499 1.2×	310 0.9×	285 1.7×	154 1.1×	125 1.2×	56	868
Antonio Chirianni Italy	17	553 1.3×	292 0.8×	429 2.5×	444 3.1×	94 0.9×	70	1.1k
María Stella Mura Italy	16	394 1.0×	349 1.0×	169 1.0×	148 1.0×	46 0.4×	31	826
Ronald D’Amico United States	19	528 1.3×	238 0.7×	364 2.2×	139 1.0×	27 0.3×	70	942
S Weller United States	15	450 1.1×	547 1.5×	215 1.3×	55 0.4×	87 0.8×	66	1.1k
Dion F. Coakley United States	18	782 1.9×	390 1.1×	536 3.2×	174 1.2×	93 0.9×	25	1.2k
Hamid Hasson Italy	13	468 1.1×	224 0.6×	345 2.0×	142 1.0×	26 0.2×	69	792

Countries citing papers authored by George Perez

Since Specialization

Citations

This map shows the geographic impact of George Perez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Perez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Perez more than expected).

Fields of papers citing papers by George Perez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Perez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Perez. The network helps show where George Perez may publish in the future.

Co-authorship network of co-authors of George Perez

This figure shows the co-authorship network connecting the top 25 collaborators of George Perez. A scholar is included among the top collaborators of George Perez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Perez. George Perez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Perez, George, Chen‐Liang Deng, Ying Yi, et al.. (2024). Deregulation of Casein Kinase-2 in non-small-cell lung cancer: A subunit-specific analysis. 3(4). 4571–4571. 1 indexed citations

2.

Perez, George, Vladimir Besada, Luis Javier González, et al.. (2022). CIGB-300 Anticancer Peptide Differentially Interacts with CK2 Subunits and Regulates Specific Signaling Mediators in a Highly Sensitive Large Cell Lung Carcinoma Cell Model. Biomedicines. 11(1). 43–43. 5 indexed citations

3.

Perez, George, Yassel Ramos, Viviana Falcón, et al.. (2022). Targeting of Protein Kinase CK2 Elicits Antiviral Activity on Bovine Coronavirus Infection. Viruses. 14(3). 552–552. 9 indexed citations

4.

Besada, Vladimir, George Perez, Yassel Ramos, et al.. (2021). Phosphoproteomic Landscape of AML Cells Treated with the ATP-Competitive CK2 Inhibitor CX-4945. Cells. 10(2). 338–338. 8 indexed citations

5.

Perez, George, Vladimir Besada, Yassel Ramos, et al.. (2021). Targeting of Protein Kinase CK2 in Acute Myeloid Leukemia Cells Using the Clinical-Grade Synthetic-Peptide CIGB-300. Biomedicines. 9(7). 766–766. 13 indexed citations

6.

Perez, George, et al.. (2012). An interesting case of Empedobacter brevis bacteremia after right knee cellulitis. Journal of Global Infectious Diseases. 4(2). 136–136. 6 indexed citations

7.

Shaaban, Hamid, et al.. (2010). The role of HIV Viral Load and CD4+ Cell Count in the prolongation of the QT interval in patients from an HIV outpatient clinic. International Journal of Infectious Diseases. 14. e79–e79. 1 indexed citations

8.

Lifson, Alan R., Waldo Belloso, Richard T. Davey, et al.. (2010). Development of Diagnostic Criteria for Serious Non-AIDS Events in HIV Clinical Trials. HIV Clinical Trials. 11(4). 205–219. 35 indexed citations

9.

Dever, Lisa L., et al.. (2009). Impact of adding maraviroc to antiretroviral regimens in patients with full viral suppression but impaired CD4 recovery. AIDS. 23(14). 1911–1913. 23 indexed citations

10.

MacArthur, Rodger D., George Perez, Sharon Walmsley, et al.. (2005). Comparison of Prognostic Importance of Latest CD4+ Cell Count and HIV RNA Levels in Patients with Advanced HIV Infection on Highly Active Antiretroviral Therapy. HIV Clinical Trials. 6(3). 127–135. 17 indexed citations

11.

Smith, Stephen M., et al.. (2005). Prevalence of GB virus type C in urban Americans infected with human immunodeficiency virus type 1. Retrovirology. 2(1). 38–38. 8 indexed citations

12.

Loutfy, Mona, et al.. (2005). CD4⁺Cell Count Increase Predicts Clinical Benefits in Patients with Advanced HIV Disease and Persistent Viremia after 1 Year of Combination Antiretroviral Therapy. The Journal of Infectious Diseases. 192(8). 1407–1411. 12 indexed citations

13.

Tedaldi, Ellen, Katherine Huppler Hullsiek, Carlos Malvestutto, et al.. (2003). Prevalence and Characteristics of Hepatitis C Virus Coinfection in a Human Immunodeficiency Virus Clinical Trials Group: The Terry Beirn Community Programs for Clinical Research on AIDS. Clinical Infectious Diseases. 36(10). 1313–1317. 52 indexed citations

14.

Hellinger, James, Marika K. Iwane, Jeffery J. Smith, et al.. (2000). A Randomized Study of the Safety and Antiretroviral Activity of Hydroxyurea Combined with Didanosine in Persons Infected with Human Immunodeficiency Virus Type 1. The Journal of Infectious Diseases. 181(2). 540–547. 18 indexed citations

15.

Matts, John P., David R. Hillman, Lawrence S. Brown, et al.. (1998). Rates of Tuberculosis Infection in Healthcare Workers Providing Services to HIV-Infected Populations. Infection Control and Hospital Epidemiology. 19(11). 829–835. 13 indexed citations

16.

Matts, John P., David R. Hillman, Lawrence S. Brown, et al.. (1998). Rates of Tuberculosis Infection in Healthcare Workers Providing Services to HIV-Infected Populations. Infection Control and Hospital Epidemiology. 19(11). 829–835. 10 indexed citations

17.

Bardeguez, Arlene, Joan Skurnick, George Perez, et al.. (1997). Lymphocyte shedding from genital tract of human immunodeficiency virus–infected women: Immunophenotypic and clinical correlates. American Journal of Obstetrics and Gynecology. 176(1). 158–165. 14 indexed citations

18.

Shepp, David H., C H Ramírez-Ronda, Lawrence Dall, et al.. (1997). A Comparative Trial of Zidovudine Administered Every Four Versus Every Twelve Hours for the Treatment of Advanced HIV Disease. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 15(4). 283–288. 6 indexed citations

19.

Denny, Thomas N., Joan Skurnick, George Perez, et al.. (1996). Lymphocyte immunoregulatory cells present in semen from human immunodeficiency virus (HIV)-infected individuals: A report from the HIV heterosexual transmission study. Cytometry. 26(1). 47–51. 8 indexed citations

20.

Jacobson, Mark Z., C. Lynn Besch, Carroll Child, et al.. (1994). Primary Prophylaxis with Pyrimethamine for Toxoplasmic Encephalitis in Patients with Advanced Human Immunodeficiency Virus Disease: Results of a Randomized Trial. The Journal of Infectious Diseases. 169(2). 384–394. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact